Back to Results
First PageMeta Content
Health / Lenalidomide / Hematologic neoplasms / Celgene / Myelodysplastic syndrome / Multiple myeloma / Thalidomide / Chromosome 5q deletion syndrome / Hematological malignancy / Medicine / Oncology / Immunosuppressants


Contact: Robert J. Hugin Senior VP and CFO Celgene Corporation[removed]
Add to Reading List

Document Date: 2012-04-18 11:53:14

Open Document

File Size: 43,48 KB

Share Result on Facebook
UPDATE